LENZ Therapeutics Stock Quote LENZ - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

22.85

Bid

21.00

Ask

22.90

Volume

0.00 Day's Range 0.00

14.42 52 Week Range 24.59

Market Cap

583.462M

Previous Close

22.85

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

201,681

Shares Outstanding

25,534,458

Dividend Yield

PE Ratio

-4.68

Earnings Per Share (EPS)

-4.88

Revenue

Net Profit

-124.65M

Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire disease-causing genes with normal genes, or insert ... Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire disease-causing genes with normal genes, or insert new genes into predetermined, safe locations. Its lead product candidate GPH101 is a differentiated approach with the potential to directly correct the mutation that causes sickle cell disease (SCD) and restore normal adult hemoglobin (HgbA) expression. All of the company's long-lived assets are based in the United States. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.lenz-tx.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

LENZ Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker LENZ. The last closing price for LENZ Therapeutics was $22.85. Over the last year, LENZ Therapeutics shares have traded in a share price range of $ 14.42 to $ 24.59.

LENZ Therapeutics currently has 25,534,458 shares outstanding. The market capitalization of LENZ Therapeutics is $583.46 million. LENZ Therapeutics has a price to earnings ratio (PE ratio) of -4.68.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.185	5.46965151165	21.665	23.01	20.86	72873	21.94485885	CS
4	5.49	31.6244239631	17.36	23.1	16.28	188489	18.71461843	CS
12	6.98	43.9823566478	15.87	23.1	14.42	201681	17.54108543	CS
26	6.87	42.9912390488	15.98	24.59	14.42	180611	17.75392932	CS
52	6.87	42.9912390488	15.98	24.59	14.42	180611	17.75392932	CS
156	6.87	42.9912390488	15.98	24.59	14.42	180611	17.75392932	CS
260	6.87	42.9912390488	15.98	24.59	14.42	180611	17.75392932	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	$ 0.1629 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 63.09 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.57 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 11.30 (0.00%)	0
AACGATA Creativity Global	$ 0.674 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1629 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 63.09 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.57 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 11.30 (0.00%)	0
AACGATA Creativity Global	$ 0.674 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1629 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 63.09 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.57 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 11.30 (0.00%)	0
AACGATA Creativity Global	$ 0.674 (0.00%)	0